Literature DB >> 18516436

Use of topical dorzolamide for patients with X-linked juvenile retinoschisis: case report.

André Luís Carvalho de Moura Bastos1, Bruno de Paula Freitas, Oscar Villas Boas, Alexandre Campelo Ramiro.   

Abstract

X-linked juvenile retinoschisis (XLRS) is a recessively inherited vitreoretinal degeneration characterized by macular pathology and splitting of the neuroretinal layers that is associated with alterations in the XLRS1 gene. There have been no therapeutic interventions known to be effective for patients with X-linked juvenile retinoschisis, but some studies are trying to determine the importance of dorzolamide for the treatment of foveal lesions in this disease. The authors, using optical coherence tomography, describe findings in a patient with X-linked juvenile retinoschisis, before and after a topical use of dorzolamide. Besides the improvement in his visual acuity, further studies are required to elucidate the real prevalence of nonresponse to dorzolamide and the frequency with which there may be a recurrence of foveal cystic changes during continued treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516436     DOI: 10.1590/s0004-27492008000200030

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  3 in total

1.  Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.

Authors:  Mohamed A Genead; Jason J McAnany; Gerald A Fishman
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

2.  Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months.

Authors:  Mark E Pennesi; David G Birch; K Thiran Jayasundera; Maria Parker; Ou Tan; Rabia Gurses-Ozden; Carrie Reichley; Kathleen N Beasley; Paul Yang; Richard G Weleber; Lea D Bennett; John R Heckenlively; Kalyani Kothapalli; Jeffrey D Chulay
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

Review 3.  Outcome measures in juvenile X-linked retinoschisis: A systematic review.

Authors:  John R Grigg; Claire Y Hooper; Clare L Fraser; Elisa E Cornish; Peter J McCluskey; Robyn V Jamieson
Journal:  Eye (Lond)       Date:  2020-04-20       Impact factor: 3.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.